Management of secondary immunodeficiency in hematological malignancies: a Delphi consensus from the Middle East

Secondary immunodeficiency (SID), acquired hypogammaglobinemia, is an immunodeficiency caused by different factors like diseases, medications, and/or nutrition disorders. Most patients with hematological malignancies (HM), namely chronic lymphocytic leukemia (CLL) and multiple myeloma (MM), experien...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Maria Dimou, Mohamed Abuzakouk, Mona Al Ahmad, Khalil Al Farsi, Ahmad Alhuraiji, Fayhan Al Roqi, Ahmed Alsaeed, Mohsen Alzahrani, Ali Bazarbachi, Honar Cherif, Riad El Fakih, Carla Irani, Faraz Khan, Iman Nasr, Hani Yousif Osman, Mustaqeem Siddiqui
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2024-03-01
Serie:	Frontiers in Hematology
Soggetti:	secondary immunodeficiency Middle East Delphi consensus immunoglobulin replacement therapy acquired hypogammaglobinemia
Accesso online:	https://www.frontiersin.org/articles/10.3389/frhem.2024.1347708/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!